Clinical & Pharmacovigilance – Page 5

PV system audit finding during benefit–risk assessment – how to strengthen benefit–risk documentation

Identifying the correct symptoms and signals from the outset is crucial for effective investigation and resolution. In the context of a PV system audit, the following indicators may suggest documentation…

PV system audit finding during benefit–risk assessment – how to strengthen benefit–risk documentation

The first step in addressing a PV system audit finding is identifying the symptoms that indicate a potential issue. Common signals include:Click to read the full article.

PV system audit finding during inspection – CAPA for PV system weaknesses

Addressing Gaps Identified in PV System Audits: An Investigative Approach Pharmaceutical professionals are often faced with the challenge of ensuring compliance within Pharmacovigilance (PV) systems, especially during regulatory inspections. When…

AE reporting non-compliance during post-marketing surveillance – how to strengthen benefit–risk documentation

In the context of AE reporting non-compliance, specific symptoms or signals may manifest that indicate a problem. These can include:Click to read the full article.

Periodic report inconsistencies during signal review – preventing repeat PV findings

Identifying signs of periodic report inconsistencies is crucial for proactive risk management. Typical symptoms can include:Click to read the full article.

Literature surveillance failure during inspection – CAPA for PV system weaknesses

Symptoms of literature surveillance failures may manifest in numerous ways, prompting immediate attention. Some common signals include:Click to read the full article.

Case processing backlog during signal review – regulatory enforcement risk and mitigation

The first step in mitigating a backlog in case processing during signal review is to recognize the symptoms that indicate a problem. Common signals may include:Click to read the full…

Case processing backlog during post-marketing surveillance – how to strengthen benefit–risk documentation

Recognizing symptoms early allows for timely interventions to mitigate the impact of case processing backlogs. Common indicators include:Click to read the full article.

Case processing backlog during benefit–risk assessment – inspection questioning scenarios

Identifying symptoms of case processing backlogs is the first step in initiating a thorough investigation. Common signals may include:Click to read the full article.